Evidence map›Paper›PMID 33818643›Full record

ArticleAIDS and behavior2021

Willingness to Use Pre-exposure Prophylaxis (PrEP) and Preferences Among Men Who have Sex with Men in Mumbai and Chennai, India: A Discrete Choice Experiment.

Venkatesan Chakrapani, Peter A Newman, Michael Cameron, Murali Shunmugam, Surachet Roungprakhon, Shruta Rawat, Dicky Baruah, Ruban Nelson, Suchon Tepjan, Riccardo Scarpa

Abstract read
PubMed Publisher
In one paragraph

Article in AIDS and behavior, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Venkatesan ChakrapaniCentre for Sexuality and Health Research and Policy (C-SHaRP), Chennai, India.ORCID http://orcid.org/0000-0001-9998-9135
Peter A NewmanFactor-Inwentash Faculty of Social Work, University of Toronto, 246 Bloor Street West, Toronto, ON, M5S1V4, Canada. p.newman@utoronto.ca.ORCID http://orcid.org/0000-0003-0444-5915
Michael CameronSchool of Accounting, Finance and Economics, Waikato Management School, University of Waikato, Hamilton, New Zealand.
Murali ShunmugamCentre for Sexuality and Health Research and Policy (C-SHaRP), Chennai, India.
Surachet RoungprakhonFaculty of Science & Technology, Rajamangala University of Technology Phra Nakhon, Bangkok, Thailand.
Shruta RawatThe Humsafar Trust, Mumbai, India.
Dicky BaruahThe Humsafar Trust, Mumbai, India.
Ruban NelsonCentre for Sexuality and Health Research and Policy (C-SHaRP), Chennai, India.
Suchon TepjanVOICES-Thailand Foundation, Chiang Mai, Thailand.
Riccardo ScarpaSchool of Accounting, Finance and Economics, Waikato Management School, University of Waikato, Hamilton, New Zealand.

Funding

CIHR MOP-102512CIHR THA-118570The Wellcome Trust DBT India Alliance IA/CPHS/16/1/502667
6 · The paper itself

Abstract

Pre-exposure prophylaxis (PrEP) programs are planned for key populations in India. We examined PrEP awareness and willingness to use PrEP in order to support products and services for MSM. From December 2016 to March 2017, we conducted a survey and discrete choice experiment (DCE)-a technique to quantify the strength of participants' trade-off preferences among various product attributes-to assess willingness to use PrEP and related preferences. MSM were recruited from cruising sites and HIV prevention services in Mumbai and Chennai. DCE data were analyzed using mixed logit regression models and estimated marginal willingness-to-pay, the relative value participants' place on different PrEP attributes. Overall, 76.6% indicated willingness to use PrEP. Efficacy had the greatest effect on choice (high vs. moderate, aOR = 19.9; 95% CI 13.0-30.4), followed by dosing frequency (intermittent vs. daily regimen, aOR = 2.02; 95% CI 1.8-2.2). Participants preferred no (vs. minor) side-effects, subsidized (vs. market) price, and government (vs. private) hospitals. Findings suggest that educational and social marketing interventions should emphasize PrEP's high efficacy and minimal side effects, and programs should provide government-subsidized PrEP with choices of intermittent or daily dosing delivered by government and private hospitals/clinics in order to optimize PrEP uptake among MSM in India.

Indexed as

HIV InfectionsPre-Exposure ProphylaxisSexual and Gender MinoritiesHomosexuality, MaleHumansIndiaMalePatient Acceptance of Health CareHIV preventionIndiaMSMPrEPStated preference methods

Identifiers

PMID33818643

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.